Pharmaceutical Product Development Stock Price, News & Analysis (NASDAQ:PPDI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Pharmaceutical Product Development (NASDAQ:PPDI)

Pharmaceutical Product Development logoPharmaceutical Product Development, Inc. is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Its development services include preclinical programs and Phase I through Phase IV clinical development services, as well as bioanalytical, cGMP, global central laboratory and vaccines and biologics laboratory services. The Company operates in two segments: Development and Discovery Sciences. In May 2009, the Company completed its disposition of its wholly owned subsidiary Piedmont Research Center, LLC. In December 2009, the Company completed its disposition of its wholly owned subsidiary PPD Biomarker Discovery Sciences, LLC. On April 2, 2009, the Company acquired Magen BioSciences, Inc. On April 21, 2009, the Company acquired AbC.R.O., Inc. On November 6, 2009, the Company acquired Excel PharmaStudies, Inc.

Receive PPDI News and Ratings via Email

Sign-up to receive the latest news and ratings for PPDI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:PPDI
CUSIPN/A
Phone+1-910-2510081

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Pharmaceutical Product Development (NASDAQ:PPDI) Frequently Asked Questions

What is Pharmaceutical Product Development's stock symbol?

Pharmaceutical Product Development trades on the NASDAQ under the ticker symbol "PPDI."

Who are some of Pharmaceutical Product Development's key competitors?

How do I buy Pharmaceutical Product Development stock?

Shares of Pharmaceutical Product Development can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Pharmaceutical Product Development?

Pharmaceutical Product Development's mailing address is 929 N Front St, WILMINGTON, NC 28401-3331, United States. The healthcare company can be reached via phone at +1-910-2510081.


MarketBeat Community Rating for Pharmaceutical Product Development (PPDI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  99
MarketBeat's community ratings are surveys of what our community members think about Pharmaceutical Product Development and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pharmaceutical Product Development (NASDAQ:PPDI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Pharmaceutical Product Development (NASDAQ:PPDI) Earnings History and Estimates Chart

Earnings by Quarter for Pharmaceutical Product Development (NASDAQ:PPDI)

Pharmaceutical Product Development (NASDAQ PPDI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2011$0.33$0.32ViewN/AView Earnings Details
2/8/2011$0.38$0.40ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Pharmaceutical Product Development (NASDAQ:PPDI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Pharmaceutical Product Development (NASDAQ:PPDI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pharmaceutical Product Development (NASDAQ PPDI)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Pharmaceutical Product Development (NASDAQ PPDI) News Headlines

Source:
DateHeadline
Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™
globenewswire.com - December 8 at 4:40 PM
Global Pharmaceutical Drug Development Services Procurement Market Report 2017 - Top Suppliers are IQVIA, LabCorp, PAREXEL, ICON & INC ResearchGlobal Pharmaceutical Drug Development Services Procurement Market Report 2017 - Top Suppliers are IQVIA, LabCorp, PAREXEL, ICON & INC Research
finance.yahoo.com - December 8 at 4:40 PM
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace® ES)Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace® ES)
www.prnewswire.com - December 4 at 4:44 PM
RDD Pharma Raises $9.5M in Series B Funding to Fuel Global DevelopmentRDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
www.prnewswire.com - November 16 at 5:46 PM
Velesco Pharma Awarded Subcontract to Develop and Manufacture Clinical Supplies for a New Treatment for Beta-ThalassemiaVelesco Pharma Awarded Subcontract to Develop and Manufacture Clinical Supplies for a New Treatment for Beta-Thalassemia
www.businesswire.com - November 8 at 3:51 PM
Versant, NEA Back Oyster Point PharmaVersant, NEA Back Oyster Point Pharma
www.businesswire.com - November 7 at 8:57 AM
Isodiol International Inc. Announces Launch of Market’s First Hops-Derived CBD ProductsIsodiol International Inc. Announces Launch of Market’s First Hops-Derived CBD Products
globenewswire.com - October 24 at 8:42 AM
Innovation Pharmaceuticals Provides Development Update On Brilacidin For Inflammatory Bowel DiseaseInnovation Pharmaceuticals Provides Development Update On Brilacidin For Inflammatory Bowel Disease
www.thestreet.com - October 24 at 8:41 AM
Isodiol International Inc. Provides Investor UpdateIsodiol International Inc. Provides Investor Update
globenewswire.com - October 19 at 7:43 AM
Isodiol International Inc. To Implement Blockchain Technology For Payment ProcessingIsodiol International Inc. To Implement Blockchain Technology For Payment Processing
www.thestreet.com - October 17 at 6:24 AM
Medibio Limited: Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.Medibio Limited: Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.
www.finanznachrichten.de - October 8 at 7:58 PM
Sales of Legal Cannabis Products are Expected to GrowSales of Legal Cannabis Products are Expected to Grow
www.prnewswire.com - October 2 at 10:21 AM
CanniMed Therapeutics Inc. and Avaria Health & Beauty Corp. to Partner on Research and Development of Cannabis-Based Topicals with Signing of LOICanniMed Therapeutics Inc. and Avaria Health & Beauty Corp. to Partner on Research and Development of Cannabis-Based Topicals with Signing of LOI
www.businesswire.com - October 2 at 10:21 AM
Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide SerumRising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum
www.marketwatch.com - October 1 at 6:23 PM
Breckenridge Pharmaceutical, Inc. and Impopharma, Inc. enter into licensing agreementBreckenridge Pharmaceutical, Inc. and Impopharma, Inc. enter into licensing agreement
www.bizjournals.com - September 30 at 5:58 PM
Acquisition Of Zevacor Pharma Complete, Rebranding As SOFIEAcquisition Of Zevacor Pharma Complete, Rebranding As SOFIE
www.prnewswire.com - September 27 at 9:24 PM
Microbial Identification Market by Product & Service, Method, Application, End User - Global Forecast to 2022Microbial Identification Market by Product & Service, Method, Application, End User - Global Forecast to 2022
www.bizjournals.com - September 26 at 7:12 PM
QuVa Pharma Announces FDA 503B Registration of its New Jersey FacilityQuVa Pharma Announces FDA 503B Registration of its New Jersey Facility
finance.yahoo.com - September 26 at 7:12 PM
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc.Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc.
www.thestreet.com - September 20 at 7:55 AM
Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices ...Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices ...
www.businesswire.com - September 20 at 7:55 AM
Q BioMed Announces Development Partnership With Sphaera PharmaQ BioMed Announces Development Partnership With Sphaera Pharma
finance.yahoo.com - September 20 at 7:55 AM
Charleston Laboratories, Inc. Reacquires Rights to Novel Investigational Treatment CL-108, for Acute Pain and Opioid-Induced Nausea and VomitingCharleston Laboratories, Inc. Reacquires Rights to Novel Investigational Treatment CL-108, for Acute Pain and Opioid-Induced Nausea and Vomiting
www.bizjournals.com - August 31 at 8:53 AM
Featured Company News - Jazz Pharma to Partner with ImmunoGen for the Development and Commercialization of Antibody-Drug Conjugate ProductsFeatured Company News - Jazz Pharma to Partner with ImmunoGen for the Development and Commercialization of Antibody-Drug Conjugate Products
www.nasdaq.com - August 31 at 8:53 AM
Athenex Pharmaceutical Division and SunGen Pharma Announce Terbutaline Sulfate Injection Product LaunchAthenex Pharmaceutical Division and SunGen Pharma Announce Terbutaline Sulfate Injection Product Launch
globenewswire.com - August 31 at 8:53 AM
Technical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSividaTechnical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSivida
www.prnewswire.com - August 30 at 8:08 AM
Global Medicated Skin Care Products IndustryGlobal Medicated Skin Care Products Industry
www.bizjournals.com - August 22 at 3:15 PM
Recro Pharma Appoints Jyrki Mattila as Executive Vice President of Business DevelopmentRecro Pharma Appoints Jyrki Mattila as Executive Vice President of Business Development
www.nasdaq.com - August 22 at 1:35 AM
Pharmaceutical Robots Market Analysis By Product, By Application, By End Use And Segment Forecasts, 2014 - 2025Pharmaceutical Robots Market Analysis By Product, By Application, By End Use And Segment Forecasts, 2014 - 2025
www.prnewswire.com - August 22 at 1:35 AM
Isodiol International Inc. July 2017 Corporate UpdateIsodiol International Inc. July 2017 Corporate Update
www.bizjournals.com - August 4 at 7:06 AM
Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira PharmaGeneric Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma
www.prnewswire.com - June 12 at 8:02 AM
Recro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting OfficerRecro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting Officer
globenewswire.com - June 6 at 8:08 AM
Acurian Announces Hiring of Tom Privette to Lead Global Business DevelopmentAcurian Announces Hiring of Tom Privette to Lead Global Business Development
www.businesswire.com - May 25 at 12:39 AM
INC Research to merge with inVentiv in latest contract medical research dealINC Research to merge with inVentiv in latest contract medical research deal
www.nasdaq.com - May 12 at 8:15 AM
Innovus Pharma Launches ProstaGorx™ Product for Prostate Health Through its Beyond Human® Sales and Marketing Platform in the United StatesInnovus Pharma Launches ProstaGorx™ Product for Prostate Health Through its Beyond Human® Sales and Marketing Platform in the United States
www.businesswire.com - May 1 at 11:23 AM
LiveLeaf and Emery Pharma Enter into an R&D Alliance for Development of Next Generation Anti-Infective DrugsLiveLeaf and Emery Pharma Enter into an R&D Alliance for Development of Next Generation Anti-Infective Drugs
www.businesswire.com - April 13 at 7:09 PM
PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty LimitedPreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited
globenewswire.com - April 13 at 9:35 AM
BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tabletBRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet
www.reuters.com - April 3 at 9:08 AM
Better Buy: Bellicum Pharmaceuticals, Inc. vs. Kite PharmaBetter Buy: Bellicum Pharmaceuticals, Inc. vs. Kite Pharma
www.fool.com - March 29 at 8:59 AM
Trump chooses Gottlieb to run FDA; Pharma breathes sigh of reliefTrump chooses Gottlieb to run FDA; Pharma breathes sigh of relief
www.reuters.com - March 10 at 9:06 PM
Pharma says high prices fund drug development. This study says otherwisePharma says high prices fund drug development. This study says otherwise
www.marketwatch.com - March 8 at 9:07 PM
LabCorp seeks to acquire N.C. clinical trials firm PPD, per reportLabCorp seeks to acquire N.C. clinical trials firm PPD, per report
www.bizjournals.com - March 4 at 7:19 PM
PPD Expands Nephrology Capabilities Through Collaboration with FrenovaPPD Expands Nephrology Capabilities Through Collaboration with Frenova
www.businesswire.com - February 22 at 9:23 AM
Heart Transplant Rejection - Pipeline Review, H2 2016 - Key Players Are Astellas Pharma Inc, Nekonal Sarl, Noxxon Pharma AG & Pelican Therapeutics - Research and MarketsHeart Transplant Rejection - Pipeline Review, H2 2016 - Key Players Are Astellas Pharma Inc, Nekonal Sarl, Noxxon Pharma AG & Pelican Therapeutics - Research and Markets
www.businesswire.com - February 8 at 2:49 AM
CanniMed Completes Initial Public OfferingCanniMed Completes Initial Public Offering
www.businesswire.com - December 29 at 9:00 AM
Lannett To Co-Develop Generic Insulin Product For U.S. MarketLannett To Co-Develop Generic Insulin Product For U.S. Market
www.rttnews.com - April 23 at 8:42 AM
PPD Strengthens Oncology Expertise for Drug DevelopmentPPD Strengthens Oncology Expertise for Drug Development
www.businesswire.com - April 15 at 8:27 AM
Halo Pharmaceutical and ExxPharma Therapeutics to Collaborate on the Development/Manufacturing of Products using Twin Screw Extrusion TechnologyHalo Pharmaceutical and ExxPharma Therapeutics to Collaborate on the Development/Manufacturing of Products using Twin Screw Extrusion Technology
www.prnewswire.com - April 15 at 8:27 AM
UPDATE - Actinium Announces Selection of Zevacor Pharma, Inc. for Clinical Production and Supply of Iomab-B for Pivotal Phase 3 SIERRA TrialUPDATE - Actinium Announces Selection of Zevacor Pharma, Inc. for Clinical Production and Supply of Iomab-B for Pivotal Phase 3 SIERRA Trial
www.msn.com - April 13 at 8:37 AM
This Triangle industry boasts 25% turnover and 7% raisesThis Triangle industry boasts 25% turnover and 7% raises
www.bizjournals.com - December 4 at 3:00 PM

SEC Filings

Pharmaceutical Product Development (NASDAQ:PPDI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pharmaceutical Product Development (NASDAQ:PPDI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pharmaceutical Product Development (NASDAQ PPDI) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.